Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.Forward-Looking Statements The statements in this press release regarding the expected benefits of using the MicroCutter 5/80 are "forward-looking statements." There are a number of important factors that could cause actual results to differ materially from those indicated by these forward-looking statements, including those described in Dextera Surgical's Annual Report on Form 10-K for the year ended June 30, 2016, under the caption "Risk Factors," filed with the U.S. Securities and Exchange Commission on October 12, 2016. Dextera Surgical expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Dextera Surgical's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.
Contact:Bob NewellVice President, Finance and Chief Financial Officer(650) email@example.comMedia:Kelly Morrison+1 (224) firstname.lastname@example.org